Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Cengiz Beyan
Esin Beyan
机构：
[1] Ufuk University Faculty of Medicine,Department of Internal Medicine
[2] University of Health Sciences,undefined
[3] Kecioren Training and Research Hospital,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Drug therapy; Mean platelet volume; Predictive value of tests; Prognosis; Prostatic neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2175 / 2176
页数：1
相关论文
共 50 条
  • [1] Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer
    Beyan, Cengiz
    Beyan, Esin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2175 - 2176
  • [2] Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer
    Yamamoto, Shimpei
    Yoshida, Soichiro
    Ishii, Chikako
    Takahara, Taro
    Arita, Yuki
    Fukushima, Hiroshi
    Tanaka, Hajime
    Yokoyama, Minato
    Matsuoka, Yoh
    Fujii, Yasuhisa
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (02) : 401 - 408
  • [3] Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020
    Wataru Fukuokaya
    Takahiro Kimura
    Fumihiko Urabe
    Shoji Kimura
    Kojiro Tashiro
    Shunsuke Tsuzuki
    Yusuke Koike
    Hiroshi Sasaki
    Kenta Miki
    Shin Egawa
    International Journal of Clinical Oncology, 2020, 25 : 2177 - 2178
  • [4] Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020
    Fukuokaya, Wataru
    Kimura, Takahiro
    Urabe, Fumihiko
    Kimura, Shoji
    Tashiro, Kojiro
    Tsuzuki, Shunsuke
    Koike, Yusuke
    Sasaki, Hiroshi
    Miki, Kenta
    Egawa, Shin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2177 - 2178
  • [5] Charlson Score as prognostic factor in patients with castration-resistant prostate cancer
    Jankilevich, Gustavo
    Gennari, Luciana
    Salazar, Matias
    Graziano, Claudio
    Saravia, Eduardo
    Belinky, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Rii, Junryo
    Yamamoto, Satoshi
    Kamada, Shuhei
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Komiya, Akira
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    PROSTATE, 2020, 80 (07): : 559 - 569
  • [7] New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
    Conteduca, Vincenza
    Mosca, Alessandra
    Brighi, Nicole
    de Giorgi, Ugo
    Rescigno, Pasquale
    CELLS, 2021, 10 (01) : 1 - 13
  • [8] Editorial for "Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer"
    Rong, Rong
    Hu, Lingzhi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (02) : 409 - 410
  • [9] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [10] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
12345